Total Funding
73
45
Total FundingSeries B raised
Growth Score
-4 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17317
Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.
About the Company
Sirius Therapeutics develops RNA interference (RNAi) therapeutics, focusing on small interfering RNA (siRNA) molecules for treating cardiovascular diseases. The company’s pipeline includes SRSD107, targeting coagulation factor XI for thromboembolic disorders, and SRSD101, aimed at treating dyslipidemia. Sirius Therapeutics is also developing
SRSD216 for hyperlipoproteinemia(a), a lipid disorder related to atherosclerotic cardiovascular disease.
